Aspirin Resistance in Cardiovascular Disease: A Review

This publication has 54 references indexed in Scilit:

• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.
  The American Journal of Cardiology, 1999
• CYCLOOXYGENASES 1 AND 2
  Annual Review of Pharmacology and Toxicology, 1998
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Development of aspirin resistance in persons with previous ischemic stroke.
  Stroke, 1994
• Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.
  Stroke, 1993
• Control of the Circulation by Endothelial Mediators
  International Archives of Allergy and Immunology, 1993
• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989
• United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results
  BMJ, 1988
• Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1988